Technology News and Research

RSS

New room temperature-based liquid formulation for storage of tissues and cells

Biomatrica, the leader in room temperature biological sample stabilization, today announced the release of DNAgard(TM), the first room temperature-based liquid formulation for stabilization and storage of tissues and cells. The new DNAgard product adds to Biomatrica's portfolio of solutions for room-temperature storage, archiving, stabilization and transportation of biological samples.

8 Dec 2009

Eidogen-Sertanty licenses its TIP technology for FDA's National Center for Toxicological Research

Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, announced today they have licensed their Target Informatics Platform (TIP) to the U.S. Food and Drug Administration's National Center for Toxicological Research (NCTR).

8 Dec 2009

TSO3 files medical device amendment for the addition of STERIZONE 125L+ Sterilizer

TSO3 Inc. ("TSO3"), an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, today announced that it has filed with Health Canada, a medical device amendment for the addition of the STERIZONE(R) 125L+ Sterilizer to the list of already cleared product for sale in Canada.

8 Dec 2009

Arcadia Biosciences' SONOVA 400 receives FDA approval as a dietary supplement ingredient

Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, announced today that it has successfully completed the U.S. Food and Drug Administration (FDA) regulatory process for SONOVA™ 400.

8 Dec 2009

HALO procedure can help manage Barrett's esophagus and prevent esophageal cancer

Cancer prevention is an important goal for all Houstonians and Bay Area Gastroenterology advises that early detection can prevent esophageal cancer.

8 Dec 2009

Tranzyme Pharma and Bristol-Myers Squibb sign collaboration agreement

Tranzyme Pharma today announced that it has entered into a strategic collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds directed against targets of interest to Bristol-Myers Squibb.

8 Dec 2009

Opportunity for wireless technologies in Western Europe's e-healthcare market

Healthcare in Europe is facing major challenges in both structural reform and unavailability of resources as the region's working population is far lower in comparison to those of 'non-working' age. This calls for the introduction of new schemes in healthcare that would enable Europe to deal with issues pertaining to the growing ageing population.

8 Dec 2009

Positive data from Onconova Therapeutics' ON 01910.Na trial for advanced MDS

Onconova Therapeutics, Inc. today announced promising results from two clinical trials in patients with advanced Myelodysplastic Syndrome (MDS) treated with ON 01910.Na. These trials are being conducted at the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, MD, and St. Vincent’s Comprehensive Cancer Center in New York.

8 Dec 2009

Cedars-Sinai Regenerative Medicine Institute supplies stem cells to aid Huntington's disease research

The Cedars-Sinai Regenerative Medicine Institute is to provide stem cells to a five-member National Institutes of Health consortium of researchers for development of potential therapies to treat Huntington's disease.

8 Dec 2009

SOLESTA pivotal study meets primary endpoints for fecal incontinence treatment

Q-Med AB and Oceana Therapeutics, Inc. today announced that the SOLESTA pivotal study succeeded in meeting both primary endpoints for the treatment of fecal incontinence.

8 Dec 2009

Pediatrician offers tips for appropriate internet and cell phone usage

In the good old days, responsible parents talked to their children about dating and sex. But these days, in our ever-changing digital world, that's not enough, says Marilyn Maxwell, M.D., professor of pediatrics and internal medicine at Saint Louis University School of Medicine.

8 Dec 2009

Market for personalized medicine in the United States to grow 11 percent annually, shows report

The market for personalized medicine in the United States is already $232 billion, and it is projected to grow 11 percent annually, according to a new report published today by PricewaterhouseCoopers LLP, entitled The Science of Personalized Medicine: Translating the Promise into Practice.

8 Dec 2009

ImmunoGen's SAR3419 holds hope for B-cell non-Hodgkin’s lymphoma

ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, today announced the presentation of encouraging initial clinical findings with SAR3419 at the American Society of Hematology (ASH) 51st Annual Meeting and Exposition. Among the findings reported were responses to SAR3419 – administered as a single agent – among patients with B-cell non-Hodgkin's lymphoma that is refractory to treatment with rituximab (Rituxan®).

8 Dec 2009

MicroPhage obtains CE mark to market MRSA/MSSA Blood Culture Test in Europe

MicroPhage announced today that it has obtained its CE Mark to market in Europe the first of its instrument-free, rapid tests based on its patented Bacteriophage Amplification technology.

8 Dec 2009

Sectra achieves increased operating profit for the first half of fiscal year

IT and medical-technology company Sectra’s (STO:SECTB) net sales for the first half of the fiscal year increased 4.9% to SEK 391.7 million (373.4) compared with the year-earlier period. Operating profit rose 87.5% to SEK 16.5 million (8.8), corresponding to an operating margin of 4.2% (2.4). Profit after net financial items amounted to SEK 4.4 million (48.2), corresponding to a profit margin of 1.1% (12.9).

8 Dec 2009

SAVI applicator for breast brachytherapy can be an effective therapy for breast cancer

The SAVI™ applicator for breast brachytherapy is a safe, effective therapy for breast cancer, according to a newly published study in a peer-reviewed journal.

8 Dec 2009

Myriant Technologies receives $50 million for biobased Succinic Acid facility in Louisiana

Myriant Technologies LLC (as successor to BioEnergy International), a leading biotech developer and manufacturer of renewable biochemicals, has been selected by the U.S. Department of Energy (DOE) to receive up to $50 million for its planned biobased Succinic Acid facility in Louisiana.

8 Dec 2009

Abstracts on very small embryonic-like stem cells presented at ASH annual meeting

NeoStem, Inc., which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need and holds the exclusive, worldwide license to VSEL(TM) technology that uses very small embryonic-like stem cells isolated from peripheral blood, announced today that an abstract authored by NeoStem-affiliated scientists was presented in a poster presentation at the prestigious American Society of Hematology (ASH) Annual Meeting in New Orleans on December 5, 2009.

8 Dec 2009

Group Health selects Avaya contact center solutions to improve patient service operations

Group Health Cooperative, one of the nation's largest consumer-governed, non-profit health care systems, selected Avaya contact center solutions to achieve greater efficiencies and faster service in their patient service operations.

8 Dec 2009

BD Diagnostics receives FDA clearance on Amplified DNA Assays

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to utilize its BD ProbeTec(TM) Chlamydia trachomatis (CT) Qx and BD ProbeTec(TM) Neisseria gonorrhoeae (GC) Qx Amplified DNA Assays with samples collected during women's routine liquid-based Pap testing for cervical cancer screening.

From BD (Becton, Dickinson and Company) 8 Dec 2009

Technology News and Research

New room temperature-based liquid formulation for storage of tissues and cells

Eidogen-Sertanty licenses its TIP technology for FDA's National Center for Toxicological Research

TSO3 files medical device amendment for the addition of STERIZONE 125L+ Sterilizer

Arcadia Biosciences' SONOVA 400 receives FDA approval as a dietary supplement ingredient

HALO procedure can help manage Barrett's esophagus and prevent esophageal cancer

Tranzyme Pharma and Bristol-Myers Squibb sign collaboration agreement

Opportunity for wireless technologies in Western Europe's e-healthcare market

Positive data from Onconova Therapeutics' ON 01910.Na trial for advanced MDS

Cedars-Sinai Regenerative Medicine Institute supplies stem cells to aid Huntington's disease research

SOLESTA pivotal study meets primary endpoints for fecal incontinence treatment

Pediatrician offers tips for appropriate internet and cell phone usage

Market for personalized medicine in the United States to grow 11 percent annually, shows report

ImmunoGen's SAR3419 holds hope for B-cell non-Hodgkin’s lymphoma

MicroPhage obtains CE mark to market MRSA/MSSA Blood Culture Test in Europe

Sectra achieves increased operating profit for the first half of fiscal year

SAVI applicator for breast brachytherapy can be an effective therapy for breast cancer

Myriant Technologies receives $50 million for biobased Succinic Acid facility in Louisiana

Abstracts on very small embryonic-like stem cells presented at ASH annual meeting

Group Health selects Avaya contact center solutions to improve patient service operations

BD Diagnostics receives FDA clearance on Amplified DNA Assays

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News